Our Fellowships and Pilot Awards

 Edward P. Evans Center for Myelodysplastic Syndromes (MDS) dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells. Each year, more than 40,000 individuals are diagnosed with MDS, and roughly one-third will develop acute myeloid leukemia (AML), a severe and rapidly progressing form of blood cancer.

To support our research, each team will receive a one-year $100,000 grant for the Edward P. Evans Center Pilot Awards and a two-year $60,000/year grant for the fellowships.